CUSTOMER ACKNOWLEDGEMENT & STATEMENT OF INTENDED USE

FORENSIC USE ONLY (FUO), EMPLOYMENT & INSURANCE USE

Effective Date: September 1, 2026
Last Updated: September 1, 2026

RapidTestCup offers drug and alcohol screening products with different regulatory classifications, intended uses, specimen types, panel configurations, and manufacturer designations.

Certain products sold by RapidTestCup / RapidTestCup.com are designated FORENSIC USE ONLY (FUO).

Other products may be designated or labeled for Employment & Insurance (E&I) applications.

Other products sold through RapidTestCup may be FDA Cleared, CLIA Waived, intended for professional use, Over-the-Counter where specifically authorized, or subject to another regulatory or intended-use designation.

Not every drug test sold by RapidTestCup has the same regulatory status or permitted use.

The purchaser, distributor, reseller, and end user are responsible for reviewing the specific product page, product packaging, package insert, Instructions for Use, labeling, regulatory designation, and intended-use information applicable to each product before purchasing or using it.

1. FORENSIC USE ONLY PRODUCTS

Products designated FORENSIC USE ONLY (FUO) are intended for appropriate forensic drugs-of-abuse screening applications.

An FUO designation does not mean that a product is FDA cleared for clinical diagnostic use.

Products that do not possess FDA clearance for clinical diagnostic use must not be advertised, represented, distributed, or used as though they possess such clearance.

Depending upon the particular product and applicable requirements, appropriate forensic users or settings may include:

  • Court systems
  • Police departments
  • Law-enforcement agencies
  • Probation departments
  • Parole departments
  • Juvenile detention facilities
  • Correctional facilities
  • Jails
  • Prisons
  • Government agencies
  • Forensic laboratories
  • Laboratories conducting appropriate forensic testing
  • Organizations performing forensic testing for qualifying judicial, correctional, governmental, or law-enforcement entities

Products designated Forensic Use Only should only be used in a manner consistent with their specific labeling and intended-use restrictions.

2. NOT FOR CLINICAL DIAGNOSIS

A product designated Forensic Use Only is not intended to diagnose, treat, cure, prevent, monitor, or identify a disease, medical condition, illness, substance-use disorder, or drug dependency.

An FUO designation is not equivalent to FDA clearance for clinical diagnostic use.

Purchasers, distributors, and resellers must not represent an FUO product as an FDA-cleared clinical diagnostic device when it does not possess such clearance.

3. AT-HOME AND OVER-THE-COUNTER USE

Unless a particular device is specifically authorized, cleared, and labeled for consumer home or Over-the-Counter use, a product designated Forensic Use Only should not be represented or marketed as an At-Home or OTC diagnostic device in the United States or its territories.

Purchasers, distributors, and resellers are responsible for preserving the applicable regulatory designation and intended-use restrictions when advertising, marketing, reselling, or redistributing products purchased from RapidTestCup.

The fact that a product may be available for online purchase does not automatically mean that it is cleared or authorized for consumer home diagnostic use.

4. EMPLOYMENT & INSURANCE PRODUCTS

Certain drugs-of-abuse screening products may carry an Employment & Insurance intended-use designation.

Where permitted by the specific product’s labeling and regulatory classification, Employment & Insurance applications may include certain forms of:

  • Pre-employment screening
  • Workplace testing
  • Random workplace testing
  • Reasonable-suspicion testing
  • Reasonable-cause testing
  • Post-accident testing
  • Return-to-duty workplace testing
  • Insurance-related screening

An Employment & Insurance designation should not be assumed to apply to every drug-testing device or every Forensic Use Only product sold by RapidTestCup.

The regulatory designation and intended-use labeling of the specific product always controls.

5. FEDERALLY REGULATED DRUG-TESTING PROGRAMS

A product designated for Employment & Insurance use should not automatically be assumed to satisfy the requirements of a federally regulated drug-testing program.

Unless a particular device, specimen type, testing methodology, and testing process are specifically appropriate and authorized for the applicable program, customers should not assume that a general Employment & Insurance screening product is suitable for regulated programs involving organizations such as:

  • U.S. Department of Transportation (DOT)
  • Substance Abuse and Mental Health Services Administration (SAMHSA)
  • U.S. Military
  • Other federal agencies or federally regulated drug-testing programs

Organizations conducting federally regulated testing are responsible for ensuring compliance with all applicable requirements.

Depending upon the program, these requirements may include:

  • Authorized specimen type
  • Collection procedures
  • Chain-of-custody requirements
  • Laboratory testing
  • Confirmatory testing
  • Medical Review Officer requirements
  • Laboratory certification requirements
  • Documentation
  • Reporting
  • Record retention
  • Other applicable federal procedures

Purchasing a drug test from RapidTestCup does not by itself establish compliance with a federal drug-testing program.

6. SPECIALTY AND EMERGING DRUG TESTS

RapidTestCup carries commonly used drug-testing configurations as well as products that screen for specialty, emerging, or less commonly tested analytes.

Depending upon the manufacturer, device, panel configuration, labeling, and regulatory status, certain tests may be designated Forensic Use Only or may carry another restricted intended-use designation.

Examples of analytes that may appear in specialty screening products include:

  • Fentanyl (FEN/FYL)
  • Xylazine (XYL)
  • Tianeptine / ZaZa (TIA)
  • Kratom (KRA)
  • Synthetic Marijuana / K2 / Spice
  • Ethyl Glucuronide (EtG)
  • Alcohol (ALC)
  • Cotinine (COT)
  • Ketamine (KET)
  • Lysergic Acid Diethylamide (LSD)
  • Methaqualone (MQL)
  • MDPV and certain synthetic cathinones
  • Psilocybin or mushroom-related screening configurations
  • Other emerging or non-standard analytes

The presence of a particular analyte does not automatically determine a product’s regulatory classification.

Two products that test for the same substance may have different:

  • Regulatory statuses
  • Intended uses
  • Specimen types
  • Cutoff levels
  • Manufacturer labeling

Customers should rely on the classification and labeling of the specific product being purchased.

7. FENTANYL TESTING PRODUCTS

RapidTestCup offers fentanyl screening products in different formats. The site currently includes products explicitly labeled Forensic Use Only as well as CLIA Waived products, demonstrating why the individual device designation matters.

Fentanyl-testing formats may include:

  • Urine drug test cups
  • Dip cards
  • Test strips
  • Multi-panel devices
  • Oral-fluid devices
  • Other testing formats

Different fentanyl-testing products may have different intended uses and regulatory classifications.

Customers should not assume that all fentanyl tests possess the same FDA, CLIA, FUO, professional-use, Employment & Insurance, or other regulatory designation simply because each product screens for fentanyl.

Always review the designation applicable to the particular fentanyl product.

8. ORAL FLUID AND SALIVA TESTING

Some oral-fluid or saliva drug-testing devices may be designated Forensic Use Only or otherwise have intended-use restrictions.

Regulatory status does not automatically transfer from one specimen type to another.

For example, the regulatory classification of a urine drug-testing device should not be assumed to apply to an oral-fluid or saliva device merely because both devices test for similar drugs.

Customers are responsible for verifying the specific regulatory status and intended use applicable to the oral-fluid or saliva product being purchased.

9. RAPID TESTS ARE SCREENING DEVICES

Unless the manufacturer’s labeling expressly states otherwise, rapid drugs-of-abuse tests should generally be treated as screening devices.

A:

  • Preliminary positive
  • Presumptive positive
  • Non-negative
  • Reactive screening result

should not automatically be treated as a definitive laboratory-confirmed result.

Where confirmation is required by:

  • Law
  • Regulation
  • Employer policy
  • Court procedure
  • Correctional policy
  • Insurance requirements
  • Professional standards
  • Other applicable rules

an appropriate laboratory confirmation procedure should be used.

Customers are responsible for determining when confirmatory testing is necessary for their particular testing program.

10. COLLECTION, SPECIMEN HANDLING & CHAIN OF CUSTODY

Organizations using drug-testing products are responsible for creating and maintaining collection and specimen-handling procedures appropriate for their particular testing program.

Depending upon the use, procedures may need to address:

  • Donor identification
  • Specimen collection
  • Specimen integrity
  • Adulteration testing
  • Chain-of-custody documentation
  • Secure specimen handling
  • Result documentation
  • Laboratory confirmation
  • Medical Review Officer review
  • Confidentiality
  • Record retention
  • Reporting procedures
  • Disposal of specimens or testing materials

RapidTestCup supplies testing products but does not control each customer’s testing program, collection procedures, interpretation procedures, or compliance program.

11. PRODUCT LABELING AND INSTRUCTIONS CONTROL

Customers must read and follow the manufacturer’s instructions and documentation applicable to the specific device being used.

These may include:

  • Instructions for Use
  • Package inserts
  • Product labeling
  • Cutoff concentrations
  • Specimen requirements
  • Collection instructions
  • Timing requirements
  • Result interpretation requirements
  • Warnings
  • Limitations
  • Storage requirements
  • Expiration information
  • Quality-control procedures

Information provided on RapidTestCup.com is intended to assist customers with product selection and general product information.

Website descriptions, advertising materials, graphics, educational content, and general explanations do not replace the manufacturer’s official instructions or regulatory labeling.

If information on the Website appears to conflict with the official labeling supplied with a product, customers should contact RapidTestCup for clarification before using the product.

12. NO MEDICAL DIAGNOSIS

Rapid drugs-of-abuse screening devices should not be used as substitutes for appropriate medical evaluation, clinical diagnosis, professional treatment, or laboratory confirmation when those services are necessary.

RapidTestCup sells drug and alcohol screening products.

RapidTestCup does not diagnose:

  • Medical conditions
  • Substance-use disorders
  • Drug dependency
  • Addiction
  • Illnesses
  • Other health conditions

through the sale of a drug-testing product.

Questions involving medical diagnosis, treatment, medication, substance dependence, or health conditions should be directed to an appropriate qualified healthcare professional.

13. CUSTOMER RESPONSIBILITY

The purchaser and end user are responsible for determining whether a particular testing product is appropriate and lawful for their intended application.

Customers should consider factors including:

  • Intended use
  • Product regulatory classification
  • Testing environment
  • Intended end user
  • Applicable jurisdiction
  • Specimen type
  • Purpose of testing
  • Applicable employer policy
  • Applicable court or correctional requirements
  • Applicable insurance requirements
  • Applicable federal, state, and local laws
  • Requirements for confirmatory testing

Drug-testing laws and procedures may differ significantly depending upon location and purpose.

Employment drug-testing requirements, for example, may vary based upon federal law, state law, local law, industry, employer policies, and the type of testing program involved.

Customers are responsible for obtaining appropriate legal, regulatory, medical, or compliance guidance when necessary.

14. DISTRIBUTORS AND RESELLERS

Customers who distribute, resell, relabel, market, advertise, or otherwise provide products purchased from RapidTestCup to another party are responsible for accurately communicating each product’s regulatory classification and intended-use limitations.

A distributor or reseller must not knowingly:

  • Remove or conceal an FUO designation.
  • Represent an FUO product as FDA cleared for clinical diagnostic use when it is not.
  • Advertise an FUO product as an authorized consumer home test when that designation does not apply.
  • Make unsupported medical claims.
  • Make unsupported diagnostic claims.
  • Change or misrepresent a product’s intended use.
  • Make FDA, CLIA, regulatory, or clearance claims that are not supported by the applicable product.
  • Represent one product’s regulatory classification as applying to another product without appropriate support.

Distributors and resellers remain independently responsible for claims, statements, marketing materials, advertisements, instructions, representations, or product descriptions they provide to their customers.

15. REGULATORY CLASSIFICATION MAY VARY BY PRODUCT

RapidTestCup sells multiple drug-testing formats and configurations.

Products may differ based upon:

  • Manufacturer
  • Number of panels
  • Drugs or analytes detected
  • Cutoff concentrations
  • Specimen type
  • Product format
  • Product configuration
  • Package labeling
  • Intended use
  • Regulatory clearance
  • CLIA status

Customers should not determine regulatory status solely from:

  • Number of panels
  • Drugs detected
  • Product appearance
  • Product name
  • Cup style
  • Strip style
  • Test format
  • Packaging
  • Similarity to another drug test
  • A previous version of a product

The regulatory classification, manufacturer labeling, and intended-use designation applicable to the specific product control.

16. PRODUCT PAGE CLASSIFICATIONS

RapidTestCup makes reasonable efforts to identify relevant product classifications and intended-use restrictions on product pages and in available product information.

These classifications may include designations such as:

  • FDA Cleared
  • CLIA Waived
  • Forensic Use Only
  • Employment & Insurance
  • Professional Use
  • Over-the-Counter
  • Other applicable regulatory or intended-use designations

RapidTestCup’s current site itself distinguishes products as CLIA Waived or Forensic Use Only, rather than treating all products as having one regulatory status.

Because RapidTestCup carries products from different manufacturers and product lines, customers should evaluate each individual product separately.

If there appears to be a conflict between information on RapidTestCup.com and official manufacturer labeling, package inserts, or device documentation, customers should contact RapidTestCup before using, marketing, distributing, or reselling the product.

Official regulatory labeling applicable to the specific device takes precedence over general Website marketing or educational content.

17. CUSTOMER ACKNOWLEDGEMENT

By purchasing, receiving, distributing, reselling, marketing, or using a product designated FORENSIC USE ONLY, EMPLOYMENT & INSURANCE, or otherwise subject to an intended-use limitation, the purchaser acknowledges and agrees that:

  1. The purchaser has reviewed or will review the regulatory classification, labeling, instructions, and intended-use designation applicable to the product.
  2. The purchaser is responsible for determining whether the product is appropriate for the purchaser’s intended testing application.
  3. The purchaser will not knowingly use, advertise, distribute, resell, or represent a product in a manner inconsistent with its applicable intended-use designation.
  4. The purchaser is responsible for complying with all applicable federal, state, and local requirements.
  5. The purchaser understands that a product being offered for sale on RapidTestCup.com does not mean that the product is legally or appropriately usable for every possible testing application.
  6. The purchaser understands that products that appear similar or test for the same drugs may possess different regulatory classifications.
  7. The purchaser understands that products sold as Forensic Use Only are not automatically FDA cleared or CLIA Waived.
  8. The purchaser understands that Employment & Insurance products are not automatically approved for DOT, SAMHSA, or other federally regulated drug-testing programs.
  9. The purchaser is responsible for determining whether laboratory confirmation, chain-of-custody procedures, Medical Review Officer review, or other procedures are required.
  10. The purchaser will contact RapidTestCup before purchasing or using a product if the product’s intended-use designation or regulatory status is unclear.

18. QUESTIONS ABOUT PRODUCT CLASSIFICATION

If you are uncertain whether a product sold by RapidTestCup is:

  • FDA Cleared
  • CLIA Waived
  • Forensic Use Only
  • Employment & Insurance
  • Professional Use
  • Over-the-Counter
  • Or subject to another regulatory or intended-use restriction

please contact RapidTestCup before purchasing, distributing, reselling, advertising, or using the product.

Customers should not rely solely on the regulatory classification of another product that looks similar or screens for similar analytes.

19. CONTACT RAPIDTESTCUP

For product questions, intended-use questions, or clarification regarding a product’s designation, contact:

RapidTestCup
801 N Congress Ave.
Unit 499 B
Boynton Beach, FL 33426
United States

Telephone: 855-762-2877 (855-POC-CUPS)
Email: Steve@rapidtestcup.com
Website: RapidTestCup.com

The address, main contact email, and toll-free phone above match the current RapidTestCup site/footer.

IMPORTANT CUSTOMER NOTICE

A PRODUCT’S SPECIFIC LABELING, REGULATORY CLASSIFICATION, AND INTENDED-USE DESIGNATION CONTROL.

Do not assume that one drug-testing product has the same regulatory classification as another product merely because the products:

  • Test for the same drug
  • Contain the same number of panels
  • Look similar
  • Use the same specimen type
  • Have similar names
  • Are sold on the same Website

By purchasing, receiving, distributing, reselling, or using a product labeled Forensic Use Only, Employment & Insurance, or otherwise subject to an intended-use restriction, the purchaser acknowledges responsibility for using and distributing that product consistently with its specific labeling, intended use, and applicable law.

We are here to assist you every step of the way.